BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Association for Geriatric Psychiatry - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:American Association for Geriatric Psychiatry
X-ORIGINAL-URL:https://aagponline.org
X-WR-CALDESC:Events for American Association for Geriatric Psychiatry
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240112T151500
DTEND;TZID=America/New_York:20240112T161500
DTSTAMP:20260425T180945
CREATED:20240108T214429Z
LAST-MODIFIED:20240322T185207Z
UID:10000007-1705072500-1705076100@aagponline.org
SUMMARY:AAGP Journal Club: Lecanemab in Early Alzheimer's Disease
DESCRIPTION:**PLEASE NOTE: SESSION BEGINS AT 3:15 PM ET** \nJoin the AAGP Journal Club and presenter Christopher van Dyck\, MD at 3:15 pm Eastern Time on Friday. January 12\, 2024. Dr. van Dyck will not only be discussing the results of this phase 3 clinical trial (CLARITY-AD) but will also discuss some unpublished data from the open-label extension of the study. \nAbstract \nACCME Credit Designation Statement:\nAmedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians.\nPhysicians should claim only the credit commensurate with the extent of their participation in the activity. \nLearning Objectives:\n1. Develop an understanding of the evidence behind the FDA approval of Lecanemab for use in early Alzheimer's disease based on the results of the CLARITY-AD phase 3 clinical trial.\n2. Develop an understanding of the difference between disease-modifying therapies (Lecanemab) and symptomatic therapies (Donepezil) for the treatment of Alzheimer's disease. \nHow to Get Your Certificate\n1. Go to aagp.cmecertificateonline.com\n2. Click on the American Association for Geriatric Psychiatry Journal Club – Lecanemab Therapy in Early\nAlzheimer’s Disease link.\n3. Evaluate the meeting.\n4. Print\, download\, or save your certificate for your records.\n5. If you lose your certificate\, or need help\, go to help.cmecertificateonline.com \n  \n  \nView Recording
URL:https://aagponline.org/event/aagp-journal-club-lecanemab-in-early-alzheimers-disease/
END:VEVENT
END:VCALENDAR